07/31
2020

Procedures & Technical Requirements for Drug Registration Inspection (Version 2020)

07/01
2020

Charging Rates for Drug Registration

Charging Rates for Drug Registration

04/08
2020

Baidu promotion materials

Baidu promotion materials

03/23
2020

Policy updates (as at 16th July 2019) (56th Announcement in 2019)

Policy updates (as at 16th July 2019) (56th Announcement in 2019)

03/23
2020

Ports that are approved by the State Council of China for importing pharmaceutical materials

The 22 ports that are approved by the state council of China to import pharmaceutical materials into China (as at July 2019)

03/18
2020

VAT Discounts for the First Batch of Orphan Drugs Officially Landed

VAT Discounts for the First Batch of Orphan Drugs Officially Landed

03/18
2020

NMPA Issued the Announcement on the Cessation of Production, Sale and Use of Furazolidone-Containing

NMPA Issued the Announcement on the Cessation of Production, Sale and Use of Furazolidone-Containing Compound Preparations

03/18
2020

NMPA Issued the Announcement on Revising the Package Inserts of Cefoperazone-Containing Drugs

NMPA Issued the Announcement on Revising the Package Inserts of Cefoperazone-Containing Drugs

03/18
2020

NMPA Issued the Announcement on the Selection and Determination Procedures for Reference Formulation

NMPA Issued the Announcement on the Selection and Determination Procedures for Reference Formulations of Chemical Generic Drugs

03/18
2020

NMPA Issued the Guidelines for the Collection and Reporting of Adverse Drug Reactions in Individual

NMPA Issued the Guidelines for the Collection and Reporting of Adverse Drug Reactions in Individual Cases